Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR007730)
Formula
SVG example
Unclear
Reactant Hydroxyflutamide metabolite M1 Product Hydroxyflutamide metabolite Flu-1
Reactant Info Product Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007729 Hydroxyflutamide Hydroxyflutamide metabolite M1 Unclear - Unclear Hydroxyflutamide [1]
MR005054 Flutamide Metabolite M1 Flutamide Metabolite M7 Unclear Flutamide [2]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007736 Hydroxyflutamide metabolite M1 Hydroxyflutamide metabolite M1 glucuronide Unclear - Unclear Hydroxyflutamide [1]
MR007735 Hydroxyflutamide metabolite M1 Hydroxyflutamide metabolite M3 Unclear - Unclear Hydroxyflutamide [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005049 Flutamide Flutamide Metabolite M3 Unclear Flutamide [2]
MR007734 Hydroxyflutamide Hydroxyflutamide metabolite Flu-1 Unclear - Unclear Hydroxyflutamide [1]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005052 Flutamide Metabolite M3 Flutamide Metabolite M4 Unclear Flutamide [2]
MR005050 Flutamide Metabolite M3 Flutamide Metabolite M5 Unclear Flutamide [2]
MR014049 Hydroxyflutamide metabolite Flu-1 Hydroxyflutamide metabolite Flu-3 Unclear - Unclear Hydroxyflutamide [1]
References
1 Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry
2 Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.